Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (571-580 of 999) with videos related to

Pageof 100
Sort By:
The New England Journal of Medicine|May 28, 2024
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed HyperlipidemiaChristie M Ballantyne, Szilard Vasas, Masoud Azizad, et al.
American Heart Journal|December 16, 2014
High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) studyKristian B Filion, Sunil K Agarwal, Christie M Ballantyne, et al.
Circulation. Cardiovascular Quality and Outcomes|May 12, 2018
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence RegistrySalim S Virani, Kevin F Kennedy, Julia M Akeroyd, et al.
Clinical Cardiology|September 20, 2022
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)Aleesha Shaik, Mikhail Kosiborod, James A de Lemos, et al.
American Journal of Preventive Medicine|December 19, 2024
Demographic and Clinical Risk Factors of Developing Clinically Recognized Varicose Veins in Older AdultsYejin Mok, Shoshana H Ballew, Anna Kucharska-Newton, et al.
Journal of the American Heart Association|April 4, 2022
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-ITSenthil Selvaraj, Deepak L Bhatt, Ph Gabriel Steg, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 19, 2011
Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomesMahboob Alam, Sahar Siddiqui, Vei-Vei Lee, et al.
The American Journal of Cardiology|March 19, 2011
Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass graftingSalim S Virani, Ariel Brautbar, Vei-Vei Lee, et al.
Journal of the American College of Cardiology|July 7, 2018
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular DiseaseAnum Saeed, Elena V Feofanova, Bing Yu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 30, 2006
Effects of diet-induced obesity on inflammation and remodeling after myocardial infarctionGeeta D Thakker, Nikolaos G Frangogiannis, Marcin Bujak, et al.
Pageof 100

Showing results (571-580 of 999) with videos related to

Sort By:
Pageof 100
The New England Journal of Medicine|May 28, 2024
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed HyperlipidemiaChristie M Ballantyne, Szilard Vasas, Masoud Azizad, et al.
American Heart Journal|December 16, 2014
High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) studyKristian B Filion, Sunil K Agarwal, Christie M Ballantyne, et al.
Circulation. Cardiovascular Quality and Outcomes|May 12, 2018
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence RegistrySalim S Virani, Kevin F Kennedy, Julia M Akeroyd, et al.
Clinical Cardiology|September 20, 2022
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)Aleesha Shaik, Mikhail Kosiborod, James A de Lemos, et al.
American Journal of Preventive Medicine|December 19, 2024
Demographic and Clinical Risk Factors of Developing Clinically Recognized Varicose Veins in Older AdultsYejin Mok, Shoshana H Ballew, Anna Kucharska-Newton, et al.
Journal of the American Heart Association|April 4, 2022
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-ITSenthil Selvaraj, Deepak L Bhatt, Ph Gabriel Steg, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 19, 2011
Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomesMahboob Alam, Sahar Siddiqui, Vei-Vei Lee, et al.
The American Journal of Cardiology|March 19, 2011
Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass graftingSalim S Virani, Ariel Brautbar, Vei-Vei Lee, et al.
Journal of the American College of Cardiology|July 7, 2018
Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular DiseaseAnum Saeed, Elena V Feofanova, Bing Yu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 30, 2006
Effects of diet-induced obesity on inflammation and remodeling after myocardial infarctionGeeta D Thakker, Nikolaos G Frangogiannis, Marcin Bujak, et al.
Pageof 100